Beneficial Effects of Anisodamine in Shock Involved Cholinergic Anti-Inflammatory Pathway
Open Access
- 1 January 2011
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 2, 9848
Abstract
Anisodamine, an antagonist of muscarinic receptor, has been used therapeutically to improve blood flow in circulatory disorders such as septic shock in China since 1965. The main mechanism of anisodamine for anti-shock proposed in Pharmacology for Chinese medical students is to improve blood flow in the microcirculation. Here, we suggest a new mechanism for its anti-shock effect. That is, anisodamine, by blocking muscarinic receptor, results in rerouting of acetylcholine to α7 nicotinic acetylcholine receptor (α7nAChR) bringing about increased acetylcholine-mediated activation of α7nAChR and the cholinergic anti-inflammatory pathway.Keywords
This publication has 18 references indexed in Scilit:
- Dysfunction of the Cholinergic Anti-Inflammatory Pathway Mediates Organ Damage in HypertensionHypertension, 2011
- Antishock effect of anisodamine involves a novel pathway for activating α7 nicotinic acetylcholine receptor*Critical Care Medicine, 2009
- The pharmacological properties of anisodamineJournal of Applied Toxicology, 2006
- A nervous connectionNature, 2003
- Anisodamine Counteracts Lipopolysaccharide-Induced Tissue Factor and Plasminogen Activator Inhibitor-1 Expression in Human Endothelial Cells: Contribution of the NF-κB PathwayJournal of Vascular Research, 2001
- Anisodamine restores bowel circulation in burn shockBurns, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Roles of thromboxane and its inhibitor anisodamine in burn shockBurns, 1990
- SALUTARY EFFECTS OF ANISODAMINE IN MURINE TRAUMATIC SHOCK1983
- Anisodamine in treatment of some diseases with manifestations of acute microcirculatory insufficiency.1975